Skip to content

Clinical trials

Phase 2 Hepatitis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis Phase: Phase 2 Clear all

64 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20015
20034
20041
20052
20063
20076
20095
20102
20113
20122
20134
20143
20152
20162
20171
20181
20191
20202
20215
20222
20231
20251
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44
Terminated8
Recruiting3
Not yet recruiting3
Unknown status3
Active, not recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences10
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)6
Vir Biotechnology, Inc.4
National Institute of Allergy and Infectious Diseases (NIAID)3
Alexion Pharmaceuticals, Inc.2
AusperBio Therapeutics Inc.2
Brii Biosciences Limited2
Dynavax Technologies Corporation2
TaiwanJ Pharmaceuticals Co., Ltd2
ANRS, Emerging Infectious Diseases1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis64
Hepatitis C20
Hepatitis B14
Hepatitis B, Chronic12
Liver Diseases11
Hepatitis C, Chronic8
Fibrosis6
Digestive System Diseases5
Hepatitis, Chronic5
Hepatitis D4

Trials

Showing 76 to 64 of 64. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.